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Role of Neuroimaging in the Presurgical 
Evaluation of Epilepsy
Tim Wehner, MD and Hans Lüders, MD, PhD
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A  significant  minority  of  patients  with  focal  epilepsy  are  candidates  for  resective  epilepsy  surgery.  Structural  and 
functional  neuroimaging  plays  an  important  role  in  the  presurgical  evaluation  of  theses  patients.  The  most  frequent 
etiologies  of  pharmacoresistant  epilepsy  in  the  adult  population  are  mesial  temporal  sclerosis,  malformations  of 
cortical  development,  cavernous  angiomas,  and  low-grade  neoplasms.  High-resolution  multiplanar  magnetic 
resonance  imaging  (MRI)  with  sequences  providing  T1  and  T2  contrast  is  the  initial  imaging  study  of  choice  to 
detect  these  epileptogenic  lesions.  The  epilepsy  MRI  protocol  can  be  individually  tailored  when  considering  the 
patient’s  clinical  and  electrophysiological  data.  Metabolic  imaging  techniques  such  as  positron  emission  tomo-
graphy  (PET)  and  single  photon  emission  tomography  (SPECT)  visualize  metabolic  alterations  of  the  brain  in  the 
ictal  and  interictal  states.  These  techniques  may  have  localizing  value  in  patients  with  a  normal  MRI  scan.   
Functional  MRI  is  helpful  in  non-invasively  identifying  areas  of  eloquent  cortex.
Developments  in  imaging  technology  and  digital  postprocessing  may  increase  the  yield  for  imaging  studies  to 
detect  the  epileptogenic  lesion  and  to  characterize  its  connectivity  within  the  epileptic  brain.
J  Clin  Neurol  4(1):1-16,  2008
Key  Words: Epilepsy,  Surgery,  MRI,  PET,  SPECT
Received:  February  14,  2008  /  Accepted:  February  14,  2008  /  Address  for  correspondence:  Tim  Wehner,  MD
Epilepsy  Center - S51,  Neurological  Institute,  Cleveland  Clinic,  9500  Euclid  Avenue,  Cleveland,  OH  44195  USA
E-mail:  wehnert@ccf.org
INTRODUCTION
About one sixth of patients with focal epilepsy are 
resistant to current antiepileptic medications.
1  Re-
sective epilepsy surgery has the potential to render 
many of these patients seizure free.
2,3 Advances in 
brain imaging have considerably changed the clinical 
approach to the patient with epilepsy. In this review, 
we describe the current role of structural and functional 
brain imaging modalities in the presurgical evaluation 
of patients with pharmacoresistant epilepsy. We will 
focus on the main pathologies found in adult epilepsy 
patients. The role of neuroimaging in the surgical 
treatment of pediatric epilepsy has been recently 
reviewed.
4
Structural neuroimaging in the presurgical evaluation 
of epilepsy fulfills several purposes:
Demonstrating a structural brain lesion in a patient 
with seizures implies a poor chance of achieving 
seizure freedom with antiepileptic medications alone.
5-7 
On the other hand, it has been consistently shown that 
the chance of seizure freedom after epilepsy surgery 
is higher in patients with a focal lesion on MRI, 
both in temporal and frontal lobe epilepsy.
8,9 An 
epileptogenic lesion is defined as a structural radio-
graphic abnormality that is thought to be the cause 
of the patient’s epilepsy.
It is important to characterize a structural lesion in 
the brain of a patient with epilepsy, because the Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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spatial relation of the lesion to the epileptogenic zone 
varies according to the nature of the epileptogenic 
lesion. The epileptogenic zone is defined as the area 
of brain tissue indispensable for the generation of 
seizures. Its removal consequently leads to seizure 
freedom. The epileptogenic zone is a theoretical con-
struct; it cannot be directly visualized with current 
diagnostic modalities.
1
Hippocampal sclerosis and cavernous angioma are 
examples of epileptogenic lesions whose location and 
extend overlap to a high degree with the epileptogenic 
zone. Consequently, removal of the MRI abnormality 
(lesionectomy including the immediate margins of 
brain tissue surrounding the lesion) leads to seizure 
freedom in a high percentage of patients. The epilep-
togenic lesion itself may or may not have intrinsic 
epileptogenicity. Most brain tumors, for example, 
may cause epileptic seizures by mass effect and 
consequent “irritation” of the cerebral cortex in their 
proximity (for a review of mechanisms, see
10) Again, 
removal of the lesion also renders most of these 
patients seizure free.
In the presence of focal cortical dysplasia, however, 
removal of the visible lesion alone frequently does 
not lead to seizure freedom, implicating that the epilep-
togenic zone extends beyond what can be visualized 
with current structural imaging modalities.
STRUCTURAL NEUROIMAGING
Computer tomography (CT) and magnetic resonance 
imaging (MRI) are used to detect and characterize 
structural brain abnormalities.
The role of CT in the presurgical evaluation is 
very limited because the sensitivity and specificity of 
MRI for almost all pathological substrates found in 
patients with intractable epilepsy is far superior. None-
theless, CT is the imaging modality of choice in the 
emergency room evaluation of a patient presenting 
with a first seizure and an abnormal neurological 
examination.
11 However, the diagnostic yield of CT 
is minimal if the patient is neurologically intact.
12  In 
the presurgical evaluation, CT used to be superior to 
MRI in demonstrating calcifications in certain patho-
logies, such as oligodendrogliomas or tuberous sclerosis. 
Furthermore, some patients that may be surgical candi-
dates have contraindications to MRI (e. g. cardiac 
pacemaker). In these patients, CT may be useful to 
demonstrate gross brain pathology. Following place-
ment of subdural grid or depth electrodes, high 
resolution CT is employed at some epilepsy centers 
to identify the position of electrodes by fusion of a 
pre-surgical MRI and the postsurgical CT scan. For 
the reasons stated above, MRI is the cornerstone 
imaging modality in patients with epilepsy. The Inter-
national League against Epilepsy (ILAE) recommends 
MRI for every patient, unless the patient suffers from 
generalized, idiopathic epilepsy beyond reasonable 
doubt, based on history, seizure semiology, physical 
and neurological examination, and EEG.
13 Given the 
advances in MRI over the last two decades, other 
imaging modalities need to be scrutinized for their 
incremental benefit.
Brain lesions associated with pharmacoresistant 
epilepsy may be subtle and thus frequently require 
special expertise for their detection and correct 
characterization. Various MRI protocols have been 
suggested in the evaluation of candidates for epilepsy 
surgery. Key elements of such a protocol include 
sequences that provide T1 and T2 contrast (T2, T2*, 
FLAIR) in three dimensions, with slices as thin as 
possible.
14 1-2 mm coronal MPRAGE slices (which 
provide T1 contrast) are typically used to evaluate 
the temporal lobe, whereas axial slices are obtained 
if extratemporal epilepsy is suspected. Gradient-echo 
sequences are used to demonstrate calcifications, in 
particular in the setting of cavernous angiomas. The 
use of gadolinium is indicated if a tumor or an 
inflammatory lesion is suspected.
The superiority of a dedicated epilepsy MRI protocol 
over nonspecific brain MRI studies in detecting epilep-
togenic lesions has been demonstrated.
15
Information derived from the patient’s history and 
video-EEG monitoring is often used in the inter-
pretation of imaging studies, and this information 
may be used to modify the MRI protocol, for 
example to provide thin cuts through the suspected Wehner Tim and Lüders Hans. Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
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(A)                                                (B)
Figure 1. Left hippocampal sclerosis. The hippocampal formation is significantly smaller on the left (arrow) compared to the right 
on coronal T1 (A). Coronal FLAIR demonstrates subtle hyperintensity within the hippocampus on the left (arrow, B ).
lobe of origin.
Increasing the static magnetic field strength to 3 
Tesla and using a specific phased-array head coil 
further increases the yield for an MRI abnormality in 
the presurgical epilepsy evaluation.
16 These technical 
modifications revealed additional diagnostic infor-
mation in 48% of patients (n=40) compared to MRI 
performed at 1.5 T, including the detection of a 
lesion in 65% of those patients (n=23) whose MRI 
had been considered normal at 1.5 T.
We will now discuss imaging features of the main 
brain lesions associated with intractable epilepsy in 
adult patients.
HIPPOCAMPAL SCLEROSIS
Most focal epilepsies arise from the temporal lobe, 
and within these, hippocampal sclerosis (HS) is the 
most common underlying pathological substrate. The 
mesial temporal structures should be carefully evaluated 
in every patient with focal epilepsy, since dual path-
ology may be present in patients whose seizure are 
suspected to arise from the neocortical temporal lobe 
or from elsewhere.
17 Classic findings of HS are atrophy 
of the mesial temporal structures with increased signal 
on T2 weighted or FLAIR images.
18 These are easiest 
appreciated when comparing both sides within the 
same subject (Fig. 1).
Several variations in hippocampal shape have been 
described in association with HS, such as loss of 
interdigitations in the hippocampal head,
19 enlarge-
ment of the CSF space in the temporal horn of the 
lateral ventricle, and a tilt of the hippocampal forma-
tion from the horizontal towards an oblique or even 
vertical plane. The impact of these abnormalities on 
prognosis for surgical treatment is unknown.
20
An experienced clinician can detect hippocampal 
sclerosis in up to 90% of cases.
5 However, a minority 
of patients with mesial temporal lobe epilepsy does 
not demonstrate findings of HS on MRI, and some 
of these may have bitemporal abnormalities. This 
problem led to the development of quantitative 
analysis of hippocampal volumes and T2 relaxation 
times, techniques that are routinely employed only in 
selected epilepsy centers.
Manual or semiautomatic hippocampal volumetry 
is a labor intensive procedure that requires considerable 
experience and only marginally increases the yield of 
MRI for mesial temporal lobe atrophy. Hippocampal Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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volumes need to be corrected for hemispheric or 
intracranial volume and compared to a control group 
matched for age, sex and handedness. Nonetheless, 
hippocampal volumetry remains an important research 
tool in the radiographic study of mesial temporal lobe 
epilepsy, as it allows the quantification of asymmetry 
and the longitudinal study of hippocampal sclerosis.
21,22
Marked elevations in hippocampal T2 relaxation 
time have been associated with HS, whereas inter-
mediate values have been found in hippocampi with-
out the characteristic imaging findings of HS, as well 
as in the contralateral hippocampus or in hippocampi 
of patients with extratemporal epilepsy.
23 Advances in 
MRI technology allow measuring T2 relaxation times 
of several hippocampal slices in a few minutes.
24  
Due to the proximity of the temporal horn of the 
lateral ventricle, CSF may be included in the sample, 
introducing a source of error. 
Diffusion weighted imaging (DWI) and diffusion 
tensor imaging (DTI) measure the molecular motion 
of water within brain tissue. Diffusivity and anisotropy 
reflect the amplitude and directionality of the molecular 
motion and can be calculated from the DTI sequence. 
In the physiologic state, the diffusion of water is 
restricted by cell membranes. In the white matter, the 
water diffusion is typically highly anisotropic; this 
used in the reconstruction of white matter tracts 
using tractography. This technique may be helpful in 
the exploration of functional connectivity of a given 
cortical area, as well as in describing the spatial 
relationship of a lesion and important white matter 
tracts. It has been reported that this information can 
help in the planning of resective epilepsy surgery in 
order to reduce morbidity.
25
Measuring diffusivity alone takes little additional 
scanning time, making its addition to a routine epilepsy 
protocol MRI feasible. However, alterations in diffusivity 
are not necessarily appreciated on visual inspection 
and frequently require postprocessing of the scan. As 
with other imaging modalities, the majority of reported 
data refer to patients with TLE. Ictally or immediately 
postictal, the hippocampal formation ipsilateral to the 
epileptogenic zone may demonstrate decreased diffu-
sivity, likely reflecting cytotoxic edema.
26  Interictally, 
mesial temporal diffusivity may be increased. These 
changes may reflect alterations in the histoarchitecture 
of the mesial structures. The data regarding interictal 
diffusivity in the contralateral mesial temporal lobe 
are equivocal, with some studies finding decreased 
diffusivity, whereas others reporting values not signi-
ficantly different from normal controls.
27  A recent study 
showed that interictal DWI in patients with TLE and 
a normal or non-lateralizing MRI had no incremental 
benefit in the presurgical evaluation.
28
MALFORMATIONS OF CORTICAL 
DEVELOPMENT (MCD, Fig. 2)
This term comprises a spectrum of disorders that 
share a common pathogenesis. They track back to 
the development of the central nervous system in utero. 
On the one extreme of this spectrum, hemimegen-
cephaly is a rare malformation that affects an entire 
hemisphere. Imaging characteristics are abnormal 
gyration, thickened cortex, loss of gray-white matter 
differentiation, and signal changes on T2-weighted 
images.
29  Hemimegencephaly typically presents with 
intractable epilepsy in early childhood. Hemispherec-
tomy is the surgical treatment of choice. The contra-
lateral hemisphere usually appears normal on imaging; 
however this does not exclude the possibility of 
additional pathology, which may be epileptogenic as 
well.
30
Polymicrogyria, schizencephaly and lissencephaly 
are further forms of MCD characterized by abnormal 
gyration patterns. In polymicrogyria, there are too 
many small gyri separated by shallow sulci. In 
schizencephaly, an abnormal cleft is lined by poly-
microgyric cortex. Lissencephaly is characterized by 
the absence of gyri. In addition to the abnormal 
gyration patterns, MRI may demonstrate blurring of 
the grey-white junction and cortical signal abnor-
malities.
31
The few available data on patients with these 
forms of MCD who underwent epilepsy surgery 
suggest that the relationship of the anatomical lesion 
to the epileptogenic zone is complex. The visible 
structural abnormality does not necessarily contain Wehner Tim and Lüders Hans. Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
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(A)                                                (B)
Figure 2. Malformation of cortical development in the right occipital lobe. Coronal T1 (A) shows abnormally configured cortex. 
Note the mass effect on the occipital horn of the lateral ventricle. On coronal T2, the heterotopic cortex is more clearly 
appreciated (B).
the epileptogenic zone, which may occupy cortex 
that appears intact on MRI.
32  Epilepsy surgery for 
these patients is further complicated by the fact that 
anatomically abnormal areas may support cognitive 
or motor functions.
33
The same principle applies to subcortical hetero-
topias (SH) and periventricular nodular heterotopias 
(PNH). These are more subtle forms of MCD, charac-
terized by the abnormal presence of gray matter in 
the white matter. Their intrinsic epileptogenicity has 
been demonstrated using intracranial electrophysio-
logical monitoring in humans.
32 In one recent series, 
all seven patients with unilateral nodular heterotopia 
who achieved good outcome after epilepsy surgery 
had further ipsilateral MRI abnormalities (at least 
abnormal gyration patterns), and all were found to 
have architectural dysplasia or gliosis in the overlying 
cortex. Using stereo EEG, the authors found that the 
ictal onset never localized to the area of heterotopia 
alone, but always also involved overlying cortex. 
Thus, NH likely indicates a more widespread failure 
of brain development.
34
Focal cortical dysplasia (FCD) accounts for the 
majority of patients with MCD in surgical series,
32 
and a significant proportion of patients with intrac-
table focal epilepsy whose MRI is normal turn out to 
have focal cortical dysplasia.
35,36 On T1 weighted 
images, FCD is characterized by a circumscribed 
change in the thickness of the cortical mantle, 
blurring of the grey-white junction, and hyperintense 
signal relative to the normal cortex.
37 Two out of 
three of these characteristics were found in all FCD 
lesions and all three were found in 79%, irrespective 
of the size of the lesion, which varied by a factor of 
more than one hundred.
38 On FLAIR or T2, there 
may be associated radial hyperintensity in the white 
matter underlying the FCD, which mirrors the migration 
of cortical neurons during the development of the 
brain from the subependymal zone to the cortex.
36  
An expert panel recently proposed a classification of 
FCD into two types with two subtypes each, based 
on the presence of changes in the cortical architecture 
and the presence of dysplastic neurons, giant neurons, 
or balloon cells on histopathology. According to this 
classification, FCD type I is characterized by the 
absence of dysmorphic neurons or balloon cells and Journal of Clinical Neurology: Vol. 4, No. 1, 2008
- 6 -
(A)                                                (B)
Figure 3. Cavernous angioma in the right frontal lobe. Coronal T1 shows an area of mixed signal intensity involving the 
orbitofrontal cortex (arrow, A). Axial gradient echo reveals a corresponding area of low signal intensity (arrow, B).
divided into type IA (isolated architectural abnormalities) 
and type IB (architectural abnormalities plus giant or 
immature, but not dysmorphic neurons). Type II refers 
to Taylor-type FCD, defined by architectural abnor-
malities and the presence of dysmorphic neurons 
without (type IIA) or with (type IIB) balloon cells.
39  
One recent surgical series of patients with intractable 
epilepsy with pathologically proven focal cortical 
dysplasia correlated MRI findings with the above 
described histopathological classification.
40 MRI criteria 
for Taylor-type FCD were the combination of (1) 
focal areas of increased cortical thickening, (2) blurring 
of the cortical grey/white matter junction, and (3) 
marked hyperintensity of the subcortical white matter 
on T2-weighted images. MRI criteria for Non-Taylor 
type FCD were one of the above findings in isolation, 
or focal brain hypoplasia, moderate white matter 
signal abnormalities, or white matter core atrophy. 
Only 59% of patients with FCD type I had MRI 
abnormalities. Of these, 20% met all MRI criteria for 
Taylor-type FCD, whereas the findings were more 
subtle in nature in 80%. Two thirds of patients with 
histopathologically established FCD type II had MRI 
abnormalities, 90% of which met all MRI criteria for 
Taylor-type FCD. While these data suggest that MRI 
can differentiate between FCD type I and II, they 
also highlight that current MRI is only moderately 
sensitive to detect focal cortical dysplasia, since 41% 
of patients with FCD type I and 33% of patients 
with FCD type II had no MRI abnormality (40) In 
another series from the Cleveland Clinic, 31% of 
patients with FCD type I and 21% of patients with 
FCD type II had no focal MRI findings.
41
One study addressed the relationship of epilepto-
genicity and language or motor function with MRI 
appearance and findings on histopathology in patients 
with FCD.
42  Using extraoperative recordings from 
implanted subdural electrodes, the authors found no 
epileptogenicity and no motor or language function 
in cortical areas that contained balloon cells (type IIb 
in the above classification), all of which had increased 
signal on FLAIR. Epileptogenicity was found adjacent 
to areas containing balloon cells. A similar relationship 
has been described for low grade gliomas.
42
Several strategies have been suggested to increase 
the ability of MRI to detect subtle areas of MCD. 3T 
static magnetic field and phase-array head coils have  
been shown to increase the yield in particular for Wehner Tim and Lüders Hans. Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
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(A)                                                (B)
Figure 4. Dysembryoplastic neuroepithelial tumor (DNET) in the left mesial temporal lobe. Coronal T1 shows a mass with 
relatively homogenous hypointense signal (arrow, A). Coronal T2 reveals a more extensive area of hyperintense signal (B).
focal cortical dysplasia in patients whose MRI was 
considered normal at 1.5T.
16 Adjusting the epilepsy 
MRI protocol according to data gathered from the 
video-EEG evaluation, such as seizure semiology and 
interictal or ictal EEG activity may increase the sensi-
tivity of MRI to detect areas of FCD in the hands 
of an experienced reader in patients who are considered 
non-lesional even on dedicated epilepsy protocol 
studies.
36 Besides, there is evidence that MRI postpro-
cessing methods may increase the sensitivity to detect 
subtle areas of FCD by up to 30%.
43
CAVERNOUS ANGIOMAS
Cavernous angiomas are the most frequent form of 
vascular malformation to cause seizures. They are 
benign vascular lesions with thin-walled endothelial- 
lined spaces that contain hemorrhage products in 
different stages of evolution, but no normal brain 
tissue. On MRI, they have a characteristic “popcorn” 
appearance with a core of mixed signal intensities, 
reflecting various stages of blood degradation, and a 
hypointense rim, reflecting hemosiderin deposition 
(Fig. 3). Gradient echo sequences increase the sensitivity 
of MRI by demonstrating punctuate microhemorrhages 
that may not be detected on other sequences.
44 The 
hemorrhages associated with cavernous angiomas are 
considered a major factor in their epileptogenicity. 
The rates of seizure freedom after surgery are better 
when the hemosiderin-stained tissue has been removed 
as opposed to surgeries that remove only the cavernous 
angioma.
45 In the setting of a single cavernous angioma 
and consistent electro-clinical seizures, further testing 
is not required; even pure lesionectomy (without 
removal of associated hemosiderin-stained cortical 
tissue) achieved seizure-freedom in two-thirds of 
patients follow up for a mean of four years.
46 The 
results of surgery regarding seizure control in patients 
with cavernous angiomas is greatly influenced by the 
duration of the seizure disorder, i.e. patients who 
have a long history of uncontrolled epileptic seizures 
frequently can not be controlled by a simple lesionec-
tomy. These patients frequently require a more detailed 
work-up and a more extensive surgery to achieve 
seizure freedom.
47-49Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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(A)                                                (B)
Figure 5. Ganglioglioma in the right mesial temporal lobe. Coronal T1 reveals mixed signal intensity in the right hippocampal 
formation (arrow, A) and a cystic-appearing structure of hypointense signal extending into the right temporal white matter. Axial 
FLAIR demonstrates more widespread hyperintensity in the right mesial temporal structures (arrows, B).
BENIGN BRAIN TUMORS 
ASSOCIATED WITH EPILEPSY
Dysembryoplastic neuroepithelial tumors (DNETs) 
and gangliogliomas are low grade developmental brain 
tumors found in about 20% of patients who underwent 
surgery for pharmacoresistant focal epilepsy. They 
are classified as benign because they exert no mass 
effect and, in general, have stable appearance on 
serial imaging. Nonetheless, removal of the lesion is 
necessary to achieve seizure freedom and a definite 
diagnosis. Both DNET and gangliogliomas are charac-
terized by iso- or hypointense signal on T1 weighted 
images and hyperintensities on T2-weighted images 
(Fig. 4, 5). They both do not respect the grey-white 
matter junction, and both may have variable degree 
of enhancement after administration of contrast en-
hancement. For these reasons, they cannot be reliably 
differentiated from each other and from other forms 
of low grade gliomas using current MRI techniques.
4  
However, there are reports that PET (discussed in 
more detail below) can differentiate them. DNETs 
had low uptake on 11-C-Methionine PET, a finding 
that differentiates them from gangliogliomas or glio-
mas.
50,51 11-C-Flumazenil PET also showed hypometa-
bolism in five patients with DNET, compared to 
controls.
52  DNETs and gangliogliomas may be asso-
ciated with areas of epileptogenic FCD, which may 
be difficult to demonstrate on MRI.
5,53,54 Ictal SPECT 
(also discussed below) may be helpful in this situation. 
In one study, areas of hyperperfusion were restricted 
to the anatomical location of the DNET in cases without 
associated FCD, whereas areas of hyperperfusion were 
more widespread in patients with associated CD.
55
DUAL PATHOLOGY
Dual pathology refers to patients who have two 
(or more) distinct lesions on MRI, classically the 
combination of HS with another epileptogenic lesion. 
Dual pathology may imply two different epileptogenic 
lesions, a scenario in which the term “double path-
ology” has also been used. Dual pathology may, 
however, also reflect two different manifestations of 
one underlying epileptogenic process. In particular, Wehner Tim and Lüders Hans. Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
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the presence of hippocampal sclerosis might be a 
consequence of long-lasting epilepsy rather than its 
cause. The most frequent clinical scenario is the 
coexistence of HS with a malformation of cortical 
development, most commonly focal cortical dysplasia.
56 
In one recent epilepsy surgery series of 67 patients 
with focal cortical dysplasia, 43% had additional 
ipsilateral mesial temporal sclerosis.
57 Interestingly, 
the vast majority of patients with dual pathology 
(93%) had FCD type I. Given the high rate of dual 
pathology in patients with FCD, it is imperative to 
look for MRI features of hippocampal sclerosis in 
every epilepsy patient who is considered for resective 
epilepsy surgery.
17  As noted above, both DNET and 
low grade gliomas may also be associated with areas 
of FCD.
IMAGING POSTPROCESSING
METHODS
Another approach to increase the sensitivity of 
MRI is the use of post-acquisition digital processing 
methods such as texture analysis,
58 or statistic para-
metrical mapping (SPM) and voxel based morphometry 
(VBM). SPM and VBM compare brain scans on a 
voxel-by-voxel basis.
59 VBM was validated against 
manual volumetric analysis.
60 Patients with TLE and 
unilateral hippocampal atrophy were found to have 
structural brain abnormalities extending beyond the 
hippocampus, involving the cingulum, thalamus, and 
frontal lobe as well as ipsilateral temporopolar, en-
torhinal, and perirhinal white matter areas. Thus, 
VBM was able to confirm findings from studies that 
used manual segmentation of individual brain struc-
tures.
61,62  Another study confirmed widespread brain 
abnormalities in patient with TLE and imaging 
evidence of hippocampal sclerosis, but failed to 
demonstrate consistent imaging abnormalities in a 
group of patients with TLE without hippocampal 
sclerosis.
63  VBM has also been used to study gray 
matter abnormalities in patients with focal cortical 
dysplasia. VBM identified 79% of known areas of 
focal cortical dysplasia and demonstrated gray matter 
abnormalities extending beyond the visible lesion in 
59%.
64  However, the method failed to identify 21% 
of visible FCDs, which were characterized by high 
signal abnormalities, thus failing to identify the lesion 
as grey matter. In another study, VBM identified 10 
out of 11 visible areas of focal cortical dysplasia, 
and areas of abnormal gray matter concentration 
beyond the visible lesion were seen in 7 out of 10 
patients.
65 Using SPM, one recent study detected 
areas of increased T2 signal in 23 out of 45 patients 
with normal conventional MRI.
66  It remains to be 
seen if the current or future versions of SPM and 
VBM can reveal structural abnormalities in patients 
without a visible lesion on current standard MRI. A 
recent paper by the same group examined the use of 
four quantitative MRI contrast parameters in combi-
nation with SPM in patients with normal conventional 
MRI scans. The authors found abnormalities in 31% 
of lobes with putative seizure origin, however the 
specificity of these findings was low.
67  The relationship 
of such abnormalities to the seizure onset zone, 
irritative zone and epileptogenic zone remains to be 
defined. At present, these labor-intensive techniques 
may help to develop a hypothesis to guide the placement 
of intracranial electrodes in order to define the ictal 
onset zone in some patients.
67
SPM is also employed in functional imaging studies 
and was in fact developed to test hypotheses about 
functional imaging data.
FUNCTIONAL NEUROIMAGING
Functional imaging detects changes in cerebral 
metabolism or cerebral perfusion in the interictal or 
ictal state. Since these changes vary to a great degree 
ictally from interictally, it is important to have an 
EEG correlate of the patient’s brain activity at the 
time of imaging.
Positron-emission tomography (PET) is widely 
employed in the presurgical evaluation of patients 
with intractable epilepsy. Most data on PET are 
available on patients with temporal lobe epilepsy. 
18F 
fluoro-2-deoxyglucose (FDG) is the tracer most widely 
used. The area of decreased glucose utilization in Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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temporal lobe epilepsy is typically more extensive 
than the epileptogenic zone and may extend into the 
adjacent inferior frontal or parietal lobe cortex, as 
well as the ipsilateral thalamus and contralateral 
cerebellum.
68,69 Thus, 
18F-FDG PET has lateralizing 
rather than localizing value in temporal lobe epilepsy, 
and its main role is to confirm hypometabolism in 
the area considered for surgical resection. The presence 
of contralateral cortical hypometabolism predicts a 
low chance of seizure freedom after temporal lobec-
tomy,
70 and the extent of resection of brain areas 
with hypometabolism on FDG-PET correlated with 
better seizure outcome.
71 FDG-PET may offer localizing 
value in patients with TLE who do not have a 
structural abnormality on high-resolution MRI. One 
recent study
72  compared two groups of 30 patients 
with TLE. One group had MRI evidence of hippocampal 
sclerosis, whereas the patients in the other group 
were considered to have normal MRIs. Interestingly, 
this latter group had more widespread PET abnorma-
lities than the hippocampal sclerosis group. Surgical 
outcome in both groups was similar with 17 out 23 
patients being seizure-free in the group with HS vs. 
16 out of 20 in the group without HS. The only 
difference on histopathology was the presence of HS 
in all patients in the group with HS, whereas only 
one patient out of 10 in the group without HS had 
findings consistent with HS. (The other 10 patients 
operated on had resections sparing the mesial structures.) 
This led the authors to coin the term “MRI-negative 
PET-positive temporal lobe epilepsy”.
72
11C-Flumazenil (FMZ) is a marker for functional 
integrity of the GABAergic inhibitory neurotrans-
mitter system.
73 Its main value is that it may show 
increased ligand binding. This finding indicates the 
presence of a disease trait, whereas decreased ligand 
binding might be explained by regional loss of tissue 
which is commonly seen in epilepsy.
5 In patients with 
cryptogenic focal neocortical epilepsy, areas of increased 
FMZ binding in the periventricular white matter may 
imply the presence of heterotopic neurons not seen 
on MRI.
74 Increased periventricular white matter uptake 
of FMZ has also been associated with a worse outcome 
after temporal lobectomy in patients with unilateral 
hippocampal sclerosis.
75
Other ligands for different receptors (opiate-, glu-
tamate-, acetylcholine-, peripheral benzodiazepine-, 5- 
HT1A- receptors) and metabolic neurotransmitter path-
ways (monoaminooxidase type B, serotonin synthesis) 
have been tested in patients with TLE and HS 
(reviewed in
5). However, to our knowledge, no studies 
have demonstrated incremental benefit regarding 
surgical outcome for any of these ligands over MRI 
or PET using FDG or FMZ.
As it is the case with other imaging modalities, 
systematic data in patients with extratemporal lobe 
epilepsy are scarce compared to TLE. In general, 
FDG-PET in extratemporal epilepsy is less revealing. 
In cases of a clear MRI lesion, it typically shows 
hypometabolism coinciding with the lesion, with or 
without extension into the surrounding brain paren-
chyma. FDG-PET hypometabolism coinciding with 
an MRI lesion and EEG findings is a favorable 
prognostic factor for seizure freedom after epilepsy 
surgery for neocortical epilepsy.
76 Likewise, in a study 
of cryptogenic neocortical epilepsy (all patients had 
normal MRI scans), concordance of hypometabolism 
on FDG-PET with interictal EEG findings correlated 
with seizure freedom.
77 However, the localizing value 
of FDG-PET in this study was significantly worse in 
patients with extratemporal epilepsy, compared to 
patients with TLE.
Single Photon Emission Computed Tomography 
(SPECT) utilizes 
99mTc-hexamethyl-propyleneamine 
oxime (
99mTc-HMPAO) or 
99mTc-ethylcysteinate dimer 
(
99mTc-ECD) to study cerebral perfusion in the ictal 
and interictal state. Both these tracers have a rapid 
first pass uptake and a relatively long half-life. This 
allows storing them at the bedside for ictal injection 
as well as a generous time window of up to 6 hours 
postinjection to acquire the images. Ictal SPECT 
compared to the interictal study typically demon-
strates areas of regional hyperperfusion, which reflects 
relative hypermetabolism in parts of the brain involved 
in seizure onset or propagation.
78
Subtraction of the interictal from the ictal study 
and coregistration to the patient’s MRI improves the 
interpretation of the study.
79  Seizure type and duration Wehner Tim and Lüders Hans. Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
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Figure 6. Convergent multimodal imaging in a patient with intractable left frontal lobe epilepsy. SISCOM demonstrated a cluster 
of hyperperfusion in the left superior frontal gyrus, consistent with the patient’s ictal EEG. A subtle linear hyperintensity 
extending from the periventricular area to the left superior frontal sulcus is seen on the corresponding coronal FLAIR MRI slice. 
18-FDG PET shows mildly reduced metabolism in the overlying cortex. Invasive video EEG using a combination of grid and 
depth electrodes revealed ictal onset from this area. Histopathology after prefrontal lobectomy showed focal cortical dysplasia.
and the timing of the injection after the seizure onset 
are important variables in the interpretation of the 
study. Early injection yields better results.
80 Local 
ictal hyperperfusion is followed by postictal hypoper-
fusion within 1-2 minutes in temporal lobe seizures; 
this switch may occur even earlier in extratemporal 
seizures. It has been estimated that the seizure should 
last at least 10 seconds after the injection in order to 
obtain localizing information.
78 It is also important to 
have a video-EEG correlate of the seizure during 
which the injection occurred. Ictal SPECT is most 
helpful if the patient has stereotypic seizures; if there 
is more than one seizure type, each type may have 
to be captured. Because all these parameters have to 
be considered in the interpretation of an ictal SPECT 
study, it is difficult to systematically investigate the 
usefulness of this imaging modality. Many studies on 
ictal SPECT have included patients with clear structural 
abnormalities. It is unclear if SPECT adds anything 
in this scenario.
69  Ictal SPECT is likely most useful 
in patients with nonlesional extratemporal focal epilepsy, 
where it may help to develop a hypothesis to guide 
the placement of intracranial electrodes in order to define 
the ictal onset zone (Fig. 6).
81,82 One group reported 
that in selected cases ictal SPECT may obviate the 
need for invasive electrographic evaluations in patients 
without obvious structural lesions.
83
Functional MRI (fMRI) identifies changes in cerebral 
blood flow by measuring MRI contrast differences 
between oxygenated and deoxygenated hemoglobin. 
Increased cerebral blood flow is thought to represent 
functional activation of the surrounding cortex. In 
the presurgical epilepsy evaluation, fMRI may be 
used to define eloquent cortex. In a recent prospective 
study of 60 epilepsy surgery candidates, fMRI results 
changed patient management in about half of the 
patients.
84
Primary sensorimotor areas can be readily identified 
non-invasively by fMRI, and the results correlate 
well, but not perfectly, with those of cortical stimulation 
and evoked potentials.
85-87 Areas of activation on 
fMRI and corresponded with eloquent cortex by intra-
operative cortical mapping within 10 mm in 86% 
and within 20 mm in 100% of paradigms studied.
88  
Another study of adult brain tumor patients quoted 
90% of positive motor activations in areas activated 
on fMRI, and the remaining ones within 15 mm of 
the corresponding area.
87  This spatial “resolution” is 
within the magnitude of the resolution of electro-
cortical stimulation with typical interelectrode distances Journal of Clinical Neurology: Vol. 4, No. 1, 2008
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of 10 mm. One limitation of fMRI is that its motor 
paradigms are restricted to distal movements (e. g. 
finger or toe tapping, lip contractions).
The correlation between fMRI with various neuro-
psychological tests and the intracarotid amybarbital 
procedure (IAP, Wada-test) to predict memory decline 
after temporal lobectomy
89 and to determine the language- 
dominant hemisphere has been studied.
These studies reported that fMRI was a strong 
predictor of memory decline following a left temporal 
lobectomy in right-handed patients with left mesial 
temporal sclerosis,
90,91 as well as following right 
temporal lobectomy in patients with right temporal 
lobe epilepsy.
92 The method has also been investigated 
to lateralize language, comparing it to the Wada-test. 
Good concordance was found between Wada test and 
frontal lobe activation, but not with temporal lobe 
activation using a semantic fluency task and a story-
telling paradigm, whereas no correlation was found 
when covert sentence repetition was used as a task.
93
Correlation of language fMRI with intraoperative 
cortical stimulation also demonstrates good but not 
perfect correspondence. When allowing for 10 mm 
separation between areas of fMRI activation and areas 
identified for language on cortical stimulation, sensi-
tivity of fMRI to detect language areas was 67-100% 
for different language paradigms.
94  It has to be noted 
that the estimated error of the coregistration of intra-
operative language maps to the fMRI was estimated 
to be up to 3 mm. To our knowledge, fMRI has not 
been systematically correlated with extraoperative sti-
mulation of language areas in epilepsy patients.
In patients with extensive malformations of cortical 
development, fMRI showed activation of areas within 
the malformation, implying that areas within the 
malformed cortex may support cognitive or motor 
functions.
33
The main limitation of fMRI is its suboptimal 
specificity. A significant percentage of the cortical 
areas that are “activated” during an fMRI paradigm 
are dispensable for that specific function. Further 
work is therefore needed to clarify the role of fMRI 
in localizing eloquent cortex. At present, it has to be 
considered a research tool rather than part of the routine 
diagnostic workup of patients undergoing epilepsy 
surgery.
 
CONCLUSION
Developments in structural and functional imaging 
had a major impact on the presurgical evaluation of 
patients with pharmacoresistant epilepsy. Advances 
in MRI technology, data postprocessing and new ligands 
in PET will continue to deepen our understanding of 
structural and functional alterations in the brains of 
patients with intractable epilepsy.
Ongoing research in this field is driven by several 
questions:
(1) How can the sensitivity and specificity of MRI 
to detect subtle lesions, in particular areas of 
focal cortical dysplasia, be increased?
(2) What brain structures aside from the epilepto-
genic zone are altered in patients with focal 
epilepsy? 
(3) What is the relationship between a structural 
alteration on MRI and the epileptogenic zone? 
(4) What is the relationship between a structural 
lesion on MRI and the function of the affected 
part of the brain?
Developments in neuroimaging of epilepsy need to 
be judged by its effect on the management of patients 
with intractable epilepsy.
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